You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Solid Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen mRNA Personalised Cancer vaccine
  • (no location specified)
Jul 16, 2023

Malignant Solid Tumors Trial (2.5-3.5mCi 64Cu-FAPI-XT117, 3.5-4.5mCi 64Cu-FAPI-XT117, 4.5-5.5mCi 64Cu-FAPI-XT117)

Not yet recruiting
  • Malignant Solid Tumors
  • 2.5-3.5mCi 64Cu-FAPI-XT117
  • +2 more
  • (no location specified)
Jul 7, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

Recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital Zhejiang University School of Medi
May 11, 2023

Advanced Malignant Solid Tumors Trial in Beijing (9MW2821)

Recruiting
  • Advanced Malignant Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Mar 6, 2023

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
May 23, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • JCXH-211 Injection
  • (no location specified)
Feb 13, 2023

Malignant Tumors Trial (IMMH-010)

Enrolling by invitation
  • Malignant Neoplasms
  • Guangzhou, China
    Guangdong Provincial People's Hospital
Dec 30, 2022

Advanced Malignant Solid Tumors Trial in Shanghai (CM082)

Active, not recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 10, 2022

Solid Tumor Trial (UCLM802 Cell Injection)

Not yet recruiting
  • Solid Tumor
  • UCLM802 Cell Injection
  • (no location specified)
Mar 7, 2023

Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)

Not yet recruiting
  • Advanced Malignant Solid Tumor
  • BNT314
  • Pembrolizumab
  • Huntersville, North Carolina
    Carolina BioOncology Institute, LLC
Nov 21, 2023

Advanced Malignant Solid Tumors Trial (JCXH-212 Injection)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • JCXH-212 Injection
  • (no location specified)
Oct 11, 2022

Advanced Solid Tumors Trial in Guangzhou (JS109 combine with irinotecan)

Recruiting
  • Advanced Solid Tumors
  • JS109 combine with irinotecan
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 9, 2023

Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

Not yet recruiting
  • Digestive System Malignant Solid Tumors
  • ScTIL injection
  • ScTIL injection and B lymphocytes adjuvant
  • (no location specified)
Feb 7, 2023

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +7 more
  • CEA-targeted CAR-T cells
  • Wuhu, Anhui, China
    The First Affiliated Hospital of Wannan Medical College
Nov 9, 2023

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

Advanced Malignant Tumor Trial (HRS-2189 Tablets)

Not yet recruiting
  • Advanced Malignant Tumor
  • HRS-2189 Tablets
  • (no location specified)
May 6, 2023

Advanced Solid Tumor Trial (SHR-4602 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • SHR-4602 for injection
  • (no location specified)
Apr 6, 2023

Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))

Not yet recruiting
  • Malignant Solid Tumors
  • Sirolimus for Injection (Albumin-bound)
  • (no location specified)
Aug 19, 2022

Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Sep 9, 2022

Tumor Malignant Trial in Kashiwa-Shi, Nagoya-Shi, Sunto-Gun (SAR408701, dexamethasone, naphazoline)

Completed
  • Neoplasm Malignant
  • Kashiwa-Shi, Japan
  • +2 more
Jan 6, 2023